Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of V10153 in Acute Ischaemic Stroke
2007-007643-27Phase 2Terminated
- Sponsor
- Vernalis
- Start
- Feb 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of troplasminogen alfa in ischemic stroke, brain infarction, sponsored by Vernalis. Started Feb 2008; status: terminated.
02
Drugs
troplasminogen alfa
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on 2007-007643-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007643-27.